← Back to Search

Experimental for Breast Cancer

Phase 1
Waitlist Available
Led By Allison Magnuson, DO
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

Study Summary

This trial is testing a tool to help older adults with breast cancer make decisions about adjuvant chemotherapy.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional Assessment of the Discussion Prioritization Tool (DPT)

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Electronic completion of Geriatric Assessment and Conjoint Analysis with result output.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
846 Previous Clinical Trials
535,087 Total Patients Enrolled
11 Trials studying Breast Cancer
1,703 Patients Enrolled for Breast Cancer
Allison Magnuson, DOPrincipal InvestigatorUniv. of Rochester Wilmot Cancer Center
1 Previous Clinical Trials
85 Total Patients Enrolled
~3 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top